Megakaryocyte apoptosis in immune thrombocytopenia

The mechanisms of platelet underproduction in immune thrombocytopenia (ITP) remain unknown. While the number of megakaryocytes is normal or increased in ITP bone marrow, further studies of megakaryocyte integrity are needed. Megakaryocytes are responsible for the production of platelets in the bone...

Full description

Bibliographic Details
Main Authors: John R. Vrbensky, Ishac Nazy, Lisa J. Toltl, Catherine Ross, Nikola Ivetic, James W. Smith, John G. Kelton, Donald M. Arnold
Format: Article
Language:English
Published: Taylor & Francis Group 2018-10-01
Series:Platelets
Subjects:
Online Access:http://dx.doi.org/10.1080/09537104.2018.1475637
_version_ 1797684285318103040
author John R. Vrbensky
Ishac Nazy
Lisa J. Toltl
Catherine Ross
Nikola Ivetic
James W. Smith
John G. Kelton
Donald M. Arnold
author_facet John R. Vrbensky
Ishac Nazy
Lisa J. Toltl
Catherine Ross
Nikola Ivetic
James W. Smith
John G. Kelton
Donald M. Arnold
author_sort John R. Vrbensky
collection DOAJ
description The mechanisms of platelet underproduction in immune thrombocytopenia (ITP) remain unknown. While the number of megakaryocytes is normal or increased in ITP bone marrow, further studies of megakaryocyte integrity are needed. Megakaryocytes are responsible for the production of platelets in the bone marrow, and they are possible targets of immune-mediated injury in ITP. Since the biological process of megakaryocyte apoptosis impacts platelet production, we investigated megakaryocyte DNA fragmentation as a marker of apoptosis from ITP bone marrow biopsies. Archived bone marrow biopsy specimens from ITP patients, bone marrow specimens from controls with normal platelet counts, and bone marrow specimens from thrombocytopenic controls with myelodysplastic syndrome (MDS) were evaluated. Sections were stained with anti-CD61 for megakaryocyte enumeration, and terminal deoxynucleotidyl transferase dUTP nick-end labeling was used as an apoptotic indicator. In ITP patients, megakaryocyte apoptosis was reduced compared to nonthrombocytopenic controls. Megakaryocyte apoptosis was similarly reduced in thrombocytopenic patients with MDS. These results suggest a link between megakaryocyte apoptosis and platelet production.
first_indexed 2024-03-12T00:27:14Z
format Article
id doaj.art-a749e5bfce2549b88b7dcafe69e1c049
institution Directory Open Access Journal
issn 0953-7104
1369-1635
language English
last_indexed 2024-03-12T00:27:14Z
publishDate 2018-10-01
publisher Taylor & Francis Group
record_format Article
series Platelets
spelling doaj.art-a749e5bfce2549b88b7dcafe69e1c0492023-09-15T10:31:59ZengTaylor & Francis GroupPlatelets0953-71041369-16352018-10-0129772973210.1080/09537104.2018.14756371475637Megakaryocyte apoptosis in immune thrombocytopeniaJohn R. Vrbensky0Ishac Nazy1Lisa J. Toltl2Catherine Ross3Nikola Ivetic4James W. Smith5John G. Kelton6Donald M. Arnold7McMaster UniversityMcMaster UniversityMcMaster UniversityMcMaster UniversityMcMaster UniversityMcMaster UniversityMcMaster UniversityMcMaster UniversityThe mechanisms of platelet underproduction in immune thrombocytopenia (ITP) remain unknown. While the number of megakaryocytes is normal or increased in ITP bone marrow, further studies of megakaryocyte integrity are needed. Megakaryocytes are responsible for the production of platelets in the bone marrow, and they are possible targets of immune-mediated injury in ITP. Since the biological process of megakaryocyte apoptosis impacts platelet production, we investigated megakaryocyte DNA fragmentation as a marker of apoptosis from ITP bone marrow biopsies. Archived bone marrow biopsy specimens from ITP patients, bone marrow specimens from controls with normal platelet counts, and bone marrow specimens from thrombocytopenic controls with myelodysplastic syndrome (MDS) were evaluated. Sections were stained with anti-CD61 for megakaryocyte enumeration, and terminal deoxynucleotidyl transferase dUTP nick-end labeling was used as an apoptotic indicator. In ITP patients, megakaryocyte apoptosis was reduced compared to nonthrombocytopenic controls. Megakaryocyte apoptosis was similarly reduced in thrombocytopenic patients with MDS. These results suggest a link between megakaryocyte apoptosis and platelet production.http://dx.doi.org/10.1080/09537104.2018.1475637apoptosisautoimmune diseasebone marrow pathologyitpmegakaryocytes
spellingShingle John R. Vrbensky
Ishac Nazy
Lisa J. Toltl
Catherine Ross
Nikola Ivetic
James W. Smith
John G. Kelton
Donald M. Arnold
Megakaryocyte apoptosis in immune thrombocytopenia
Platelets
apoptosis
autoimmune disease
bone marrow pathology
itp
megakaryocytes
title Megakaryocyte apoptosis in immune thrombocytopenia
title_full Megakaryocyte apoptosis in immune thrombocytopenia
title_fullStr Megakaryocyte apoptosis in immune thrombocytopenia
title_full_unstemmed Megakaryocyte apoptosis in immune thrombocytopenia
title_short Megakaryocyte apoptosis in immune thrombocytopenia
title_sort megakaryocyte apoptosis in immune thrombocytopenia
topic apoptosis
autoimmune disease
bone marrow pathology
itp
megakaryocytes
url http://dx.doi.org/10.1080/09537104.2018.1475637
work_keys_str_mv AT johnrvrbensky megakaryocyteapoptosisinimmunethrombocytopenia
AT ishacnazy megakaryocyteapoptosisinimmunethrombocytopenia
AT lisajtoltl megakaryocyteapoptosisinimmunethrombocytopenia
AT catherineross megakaryocyteapoptosisinimmunethrombocytopenia
AT nikolaivetic megakaryocyteapoptosisinimmunethrombocytopenia
AT jameswsmith megakaryocyteapoptosisinimmunethrombocytopenia
AT johngkelton megakaryocyteapoptosisinimmunethrombocytopenia
AT donaldmarnold megakaryocyteapoptosisinimmunethrombocytopenia